Ultrahypofractionated Adjuvant Breast Radiation Therapy (± Boost) and Virtual Consultations: Patient Perspectives at 1 Year

Purpose: In March 2020, a 1-week ultrahypofractionated adjuvant breast radiation therapy schedule, 26 Gy in 5 fractions, and telehealth were adopted to reduce the risk of COVID-19 for staff and patients. This study describes real-world 1-year late toxicity for ultrahypofractionation (including a seq...

Full description

Bibliographic Details
Main Authors: Jill Theresa Nicholson, MBBS, BSc, MRCP, FFFRRCSI, Sinead Cleary, MB Bch BAO, BA, MRCPI, Gemma Farmer, MB Bch BAO, BA, MRCPI, Orla Monaghan, MB Bch BAO, BA, MRCPI, Hannah O’ Driscoll, MB Bch BAO, BA, MRCPI, Killian Nugent, MB Bch BAO, BA, MRCPI, FFRRCSI, Bahareh Khosravi, BSc, Eaine Quinlan, MB Bch BAO, BA, MRCPI, Orla McArdle, MB Bch BAO, BA, MRCPI, FFRRCSI, MSc, Fran K. Duane, MB Bch BAO, BA, MRCPI, FFRRCSI, DPhil
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Advances in Radiation Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S2452109424002318